Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1191-1200 of 1,460) with videos related to

Pageof 146
Sort By:
Plos One|September 19, 2019
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trialCristina Carter, Katherine V Houser, Galina V Yamshchikov, et al.
Clinical and Vaccine Immunology : CVI|September 22, 2006
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trialJulie E Martin, Nancy J Sullivan, Mary E Enama, et al.
JAMA|February 28, 1998
Alcohol and breast cancer in women: a pooled analysis of cohort studiesS A Smith-Warner, D Spiegelman, S S Yaun, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillanceBrandi Freeman, Sandra Lester, Lisa Mills, et al.
Nature Communications|August 2, 2022
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newbornsSimon D van Haren, Gabriel K Pedersen, Azad Kumar, et al.
BMC Medical Genetics|May 10, 2018
Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathyPatricia S Graham, Georgia Kaidonis, Sotoodeh Abhary, et al.
Plos One|April 18, 2015
Phase 1 study of pandemic H1 DNA vaccine in healthy adultsMichelle C Crank, Ingelise J Gordon, Galina V Yamshchikov, et al.
Cell Reports|September 26, 2019
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTDNianshuang Wang, Osnat Rosen, Lingshu Wang, et al.
The Lancet. Infectious Diseases|October 7, 2011
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trialsJulie E Ledgerwood, Chih-Jen Wei, Zonghui Hu, et al.
Journal of Virology|February 7, 2014
Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineagesJames R R Whittle, Adam K Wheatley, Lan Wu, et al.
Pageof 146

Showing results (1191-1200 of 1,460) with videos related to

Sort By:
Pageof 146
Plos One|September 19, 2019
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trialCristina Carter, Katherine V Houser, Galina V Yamshchikov, et al.
Clinical and Vaccine Immunology : CVI|September 22, 2006
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trialJulie E Martin, Nancy J Sullivan, Mary E Enama, et al.
JAMA|February 28, 1998
Alcohol and breast cancer in women: a pooled analysis of cohort studiesS A Smith-Warner, D Spiegelman, S S Yaun, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillanceBrandi Freeman, Sandra Lester, Lisa Mills, et al.
Nature Communications|August 2, 2022
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newbornsSimon D van Haren, Gabriel K Pedersen, Azad Kumar, et al.
BMC Medical Genetics|May 10, 2018
Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathyPatricia S Graham, Georgia Kaidonis, Sotoodeh Abhary, et al.
Plos One|April 18, 2015
Phase 1 study of pandemic H1 DNA vaccine in healthy adultsMichelle C Crank, Ingelise J Gordon, Galina V Yamshchikov, et al.
Cell Reports|September 26, 2019
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTDNianshuang Wang, Osnat Rosen, Lingshu Wang, et al.
The Lancet. Infectious Diseases|October 7, 2011
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trialsJulie E Ledgerwood, Chih-Jen Wei, Zonghui Hu, et al.
Journal of Virology|February 7, 2014
Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineagesJames R R Whittle, Adam K Wheatley, Lan Wu, et al.
Pageof 146